Bradley Gehrs to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Bradley Gehrs has written about Xenograft Model Antitumor Assays.
Connection Strength
0.077
-
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther. 2009 Jul; 8(7):1867-77.
Score: 0.077
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.